What are the payment terms?

Payment terms include LC, T/T, D/P, PayPal, Western Union, and others.

Digital Mammography System Tomosynthesis 3D High-Quality Digital Breast Cancer X Ray

Name: Digital Mammography System Tomosynthesis 3D High-Quality Digital Breast Cancer X Ray
Brand: Ningbo Cbmtec Medical Equipment Co., Ltd.
SKU: 1958414281

Zhejiang, ChinaNingbo Cbmtec Medical Equipment Co., Ltd.

US$5,000.00-8,000.00

1 Piece

Product profile

Customization

Available

Classification

Imaging Diagnostic Equipment

Type

X Ray Equipment

Model NO.

CBMTEC

Certification

CE, FDA, ISO13485

After-Sale Service

Online Technical Support

Product Name

Magnetic Resonance Imaging

Special Point

Wooden Boxes

Color

Customized

Mater

Metal

Instrument Classification

Class III

Power Source

Electric

Voltage

AC220V±10% or AC110V±10%

X-ray Energy

20-50kv

Transport Package

Wooden Boxes

Trademark

CBMTEC

Origin

China

Key features

3D Tomosynthesis Imaging: High-quality digital breast cancer X-ray with tomosynthesis technology.

CE, FDA, ISO13485 Certified: Meets international safety and quality standards for medical devices.

Customizable Color: Color is customized according to specific requirements.

High Frequency Inverter: 80kHz generator with 6kW power rating for stable performance.

Dual Focus X-ray Tube: 0.2/0.4mm focal spot with Molybdenum target and Beryllium port.

OEM and Customization: Supports OEM, special logo printing, and customization based on requests.

Professional Manufacturer: Over 5 years export experience with ISO13485 quality control system.

Fast Shipping: Shipping within 5-7 days after 100% payment via major couriers.

Company profile

Ningbo Cbmtec Medical Equipment Co., Ltd.

Zhejiang, China

Business Type: Manufacturer/FactoryExport Year: 2015-10-08Nearest Port: NingboAverage Response Time: ≤3.95hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, Others, FCA

AI-Powered supplier vetting

SummaryNingbo Cbmtec Medical Equipment Co., Ltd. is identified as a China-based manufacturer/factory operating in Zhejiang and supplying medical and industrial equipment. It reports 10 production lines, 11–20 years of total R&D-engineer experience, and 6–10 quality-control staff. Its product scope includes patient monitors, ventilators, patient lifts, anesthesia machines, ultrasound scanners, gas cylinders, oxygen concentrators, pulse oximeters, and oxygen regulators. The supplier reports BSCI, ISO 9001, and ISO 14001 management-system certifications, and began exporting in 2015, with 51%–70% of sales from exports. Evidence is insufficient to confirm after-sales service, customer cases, customization capability, or financial credibility. The available information supports manufacturing capacity and an established R&D and quality-control structure, but does not independently verify the stated quality guarantee or certification scope.

Supplier typeThe supplier is explicitly identified as a Manufacturer/Factory, with a limited-company structure and a stated factory address in Ningbo, Zhejiang, China. This directly supports classification as a manufacturing supplier rather than only a trading intermediary.

CertificationsThe supplier reports BSCI, ISO 9001, and ISO 14001 certifications under supplier management systems. These certifications are stated in the provided information, although the slices do not provide certificate numbers, validity dates, or scopes.

R&D capabilityThe supplier reports 11–20 years of total R&D-engineer experience and states that it has its own R&D and technical engineers. This supports an established internal technical base, but the slices do not document patents, proprietary technologies, new-product launches, or measurable innovation outcomes.

Production capacityThe supplier reports 10 production lines, 6–10 quality-control staff, and its own manufacturing facilities, while offering a broad range of medical and industrial equipment. These facts support operational manufacturing capability; however, the stated annual output is limited to the category reported and no capacity-utilization or delivery-performance evidence is provided.